HeartSciences Inc.
HSCS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $2 | $0 | $0 | $0 |
| % Growth | 127,215.8% | -56.3% | – | – |
| Cost of Goods Sold | $1 | $0 | $0 | -$0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 58.3% | 60% | 56.8% | – |
| R&D Expenses | $727 | $997 | $1 | $1,033 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,348 | $878 | $1 | $1,338 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$2,369 |
| Operating Expenses | $2,075 | $1,875 | $2 | $2 |
| Operating Income | -$2,073 | -$2 | -$2 | -$2,371 |
| % Margin | -85,713.2% | -98,637.8% | -44,147.1% | – |
| Other Income/Exp. Net | -$277 | -$0 | -$0 | -$165 |
| Pre-Tax Income | -$2,351 | -$2,055 | -$2 | -$2,536 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,351 | -$2 | -$2 | -$2,536 |
| % Margin | -97,179.4% | -108,157.6% | -48,145.5% | – |
| EPS | -0.85 | -1.58 | -1.88 | -2.57 |
| % Growth | 46.2% | 16% | 26.8% | – |
| EPS Diluted | -0.85 | -1.58 | -1.88 | -2.57 |
| Weighted Avg Shares Out | 3 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 3 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$280 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2,073 | -$2 | -$2 | -$2 |
| % Margin | -85,713.2% | -96,822.7% | -43,269.4% | – |